We embrace an iterative design methodology, integrating machine learning, deep domain expertise, and meticulous screening processes, to seamlessly progress from the target to promising lead compounds. This multifaceted approach allows us to refine and optimize our drug discovery endeavors, ensuring that our pursuit of innovative treatments is both scientifically rigorous and dynamically adaptive.